We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Incyte’s Retifanlimab for Rectal Cancer Should Complete Clinical Trial, Committee Says
Incyte’s Retifanlimab for Rectal Cancer Should Complete Clinical Trial, Committee Says
Incyte needs to complete another clinical trial of its proposed anal cancer treatment retifanlimab before the FDA should consider approving it, an agency advisory committee said Thursday.